Verona Pharma plc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Verona Pharma plc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2020 to Q3 2024.
  • Verona Pharma plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 652M shares, a 2.15% increase year-over-year.
  • Verona Pharma plc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 634M shares, a 19.9% increase from 2022.
  • Verona Pharma plc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 529M shares, a 11.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 652M +13.7M +2.15% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 648M +13.7M +2.17% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 646M +24.3M +3.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 634M +105M +19.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 638M +94.1M +17.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 634M +150M +30.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 621M +140M +28.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 529M +55.9M +11.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 544M +68.8M +14.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 485M +14M +2.97% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 482M +12.5M +2.66% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 473M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 475M +131M +37.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 471M +364M +343% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 469M +364M +345% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q3 2020 345M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 106M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 105M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.